Synonyms:
Status: Phase 1
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: 841P9W25WA

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Receptor tyrosine-protein kinase erbB-3 inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Neoplasms 1 D009369 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109401
FDA SRS 841P9W25WA